Christoph Nerl

3.3k citations

34 papers · 1.8k indexed · h-index 16

Impact in

Genetics top 1%
- Chronic Lymphocytic Leukemia Research
Pathology and Forensic Medicine top 1%
- Lymphoma Diagnosis and Treatment

Papers in

Genetics 10
- Chronic Lymphocytic Leukemia Research 8
Hematology 10
- Chronic Myeloid Leukemia Treatments 4
- Acute Myeloid Leukemia Research 3

Co-authors: Martin Wilhelm Bertold Emmerich Martin Lipp Reinhold Förster Peter Reimer Thomas Rüdiger Eva Geissinger Florian Weißinger
Journals: British Journal of Haematology (10 papers)Blood (9 papers)Journal of Clinical Oncology (3 papers)International Journal of Eating Disorders (1 paper)Diabetes (1 paper)
Partner nations: Germany United States Switzerland

In The Last Decade

Christoph Nerl

34 papers receiving 1.8k citations

Peers

Countries citing papers authored by Christoph Nerl

Since Specialization

Citations

This map shows the geographic impact of Christoph Nerl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Nerl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Nerl more than expected).

Fields of papers citing papers by Christoph Nerl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Nerl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Nerl. The network helps show where Christoph Nerl may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Christoph Nerl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christoph Nerl Line = papers co-authored together Christoph Nerl links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Molecular Response After 3 Months of 1st Line Imatinib Therapy Is Predictive for Treatment Failure and Disease Progression In Patients with Chronic Phase Chronic Myeloid Leukemia - a Follow-up Analysis of the German CML Study IV Blood ·Benjamin Hanfstein, Martin C. Müller, Philipp Erben, Susanne Schnittger, Susanne Saußele, Armin Leitner, Ulrike Proetel, Gerhard Ehninger, Dieter K. Hossfeld, Hans‐Jochem Kolb, Stefan W. Krause, Christoph Nerl, H. Pralle, Dominik Heim, Gabriela M. Baerlocher, H. Heimpel, Rüdiger Hehlmann, Andreas Hochhaus, (unknown)	2010	9
2	Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of a prospective multicenter study The Hematology Journal ·Peter Reimer, M. Rose, Thomas Rüdiger, Eva Geissinger, Sabine Roth, Volker Kunzmann, Florian Weißinger, Christoph Nerl, Norbert Schmitz, Hans Konrad Müller‐Hermelink, Martin Wilhelm	2004	41
3	The CD19⁺ B‐cell counts at peripheral blood stem cell mobilization determine different levels of tumour contamination and autograft purgability in low‐grade lymphoma British Journal of Haematology ·Christian Straka, Fuat Oduncu, 平田道則他, Manfred Mitterer, Fangren Xu, August König, N. Brack, Christoph Nerl, Bertold Emmerich	2002	2
4	Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group British Journal of Haematology ·Michael Hallek, Barbara Schmitt, Martin Wilhelm, Raymonde Busch, Alexander Kröber, H Ali Shakaki, Orhan Sezer, Michael Herold, Wolfgang Knauf, Clemens‐Martin Wendtner, R. Kuse, Mathias Freund, Astrid Franke, Folke Schriever, Christoph Nerl, Hartmut Döhner, Eckhard Thiel, Wolfgang Hiddemann, Günter Brittinger, Bertold Emmerich, (unknown)	2001	93
5	Intracellular and Surface Expression of the HIV-1 Coreceptor CXCR4/Fusin on Various Leukocyte Subsets: Rapid Internalization and Recycling Upon Activation The Journal of Immunology ·Reinhold Förster, Elisabeth Kremmer, Andreas Schubel, Dagmar Breitfeld, A. Kleinschmidt, Christoph Nerl, Günter Bernhardt, Martin Lipp	1998	232
6	Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose. Blood ·Wolfgang Römer, Werner Heil, Sibylle Ziegler, R. Thödtmann, Wolfgang Weber, Christoph Fuchs, W. Enne, Michael Herz, Christoph Nerl, M. Garbrecht, Markus Schwaiger	1998	272
7	Liposomal 1,25 (OH)₂ vitamin D₃ compounds block proliferation and induce differentiation in myelomonocytic leukaemia cells British Journal of Haematology ·Marion Frankenberger, Kyle Schlabach, Bertold Emmerich, Christoph Nerl, R.A. Schwendener, Angelo Milani	1997	8
8	Interferon‐alpha 2b (IFNα) for Early‐Phase Chronic Lymphocytic Leukaemia with High Risk for Disease Progression: Results of a Randomized Multicentre Study British Journal of Haematology ·Irmgard Langenmayer, Christoph Nerl, Wolfgang Knauf, محمد محمد بسيوني قنديل, Michael Hallek, 大西一正, Hermann Dietzfelbinger, Raymonde Busch, H.W.L. Ziegler-Heitbrock, Eckhard Thiel, Bertold Emmerich	1996	15
9	Regulated plasma levels of colony‐stimulating factors, interleukin‐6 and interleukin‐10 in patients with acute leukaemia and non‐Hodgkin's lymphoma undergoing cytoreductive chemotherapy British Journal of Haematology ·G. Reisbach, Emily V. Thornbury, Gerhard Welzl, Heva Lílian, Wayne Vanderhoof, Antal Lodri, Todor Gunchev, Peter G. Dormer, Christoph Nerl	1996	11
10	Clonal expansion of γδ T cells expressing two distinct T‐cell receptors British Journal of Haematology ·Thomas Hinz, H. Kassouf Kfrouy, Christoph Nerl, Dieter Kabelitz	1996	11
11	Immunocytochemical and flow cytometric detection of proteinase 3 (myeloblastin) in normal and leukaemic myeloid cells British Journal of Haematology ·Robert Dengler, Sayali Nikam, S. Al-Batran, Godwin Joseph Emeka, Stefan Faderl, Christoph Nerl, Bertold Emmerich	1995	85
12	Peripheral T‐cell non‐Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T‐zone lymphoma British Journal of Haematology ·W. Siegert, Christoph Nerl, M. Engelhard, Günter Brittinger, Markus Tiemann, Reza Parwaresch, R. Heinz, D. Huhn	1994	13
13	Immunological studies of γδ t cells in a case of large granular lymphocyte (LGL) leukemia: Leukemic γδ+ T cells are resistant to growth stimulation in vitro but respond to interferon-α treatment in vivo Leukemia Research ·Ralf Metzger, Ahmed J. Al Fahad, Christoph Nerl, S Schondelmaier, Dieter Kabelitz	1992	16
14	B‐cell chronic lymphocytic leukaemia cells express and release transforming growth factor‐β British Journal of Haematology ·양도훈, G. Reisbach, Christoph Nerl, Shunlai Sun	1992	44
15	Immunological findings in anorexia and bulimia nervosa International Journal of Eating Disorders ·Karl‐Martin Pirke, Christoph Nerl, Jürgen-Christian Krieg, Manfred M. Fichter	1992	20
16	Allergy of delayed type to recombinant interferon α 2c Contact Dermatitis ·Pablo Andrés Vidal Vargas, Monika Agathos, Christoph Nerl	1989	17
17	Flow-Cytometric Detection of Human Anti-Rat Insulinoma Antibodies in Relation to Anti-Human Islet Cell and Anti-Insulin Antibodies: Recognition of Distinct Antigens by Antibodies in Early Type I Diabetes Diabetes ·Wardah Amalia, Christoph Nerl, F Wang, Eberhard Standl, H. Mehnert	1989	1
18	CHOP and COPBLAM chemotherapy for diffuse large cell non‐Hodgkin's lymphomas: A retrospective comparison Hematological Oncology ·H. Gerhartz, Eckhard Thiel, Erhard Hiller, Christoph Nerl, H. Kolb, W. Wilmanns, D. Huhn, (unknown)	1988	5
19	HLA‐linked complement markers in Alzheimer's and Parkinson's disease Neurology ·Christoph Nerl, Richard Mayeux, Geoffrey J. O'Neill	1984	30
20	C4 polymorphism in the dog: Molecular heterogeneity of the C4? and C4? subunit chains Immunogenetics ·Mario Gerla, Christoph Nerl, H. Joachim Deeg	1984	3

About Christoph Nerl

Christoph Nerl is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Virology and Immunology, having authored 34 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (8 papers), Immune Cell Function and Interaction (6 papers), Eosinophilic Disorders and Syndromes (5 papers), T-cell and B-cell Immunology (5 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Chronic Myeloid Leukemia Treatments (4 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Genetics (630 citations), Pathology and Forensic Medicine (887 citations), Hematology (405 citations), Immunology (639 citations) and Oncology (552 citations). Christoph Nerl has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Martin Wilhelm, Bertold Emmerich, Martin Lipp, Reinhold Förster, Peter Reimer, Thomas Rüdiger, Eva Geissinger, Florian Weißinger, Norbert Schmitz and Hans Konrad Müller‐Hermelink. Their work appears in journals such as British Journal of Haematology, Blood, Journal of Clinical Oncology, International Journal of Eating Disorders and Diabetes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact